doxorubicin hydrochloride

🇺🇸 United States

FDA Page

Effective Date: Jul 9, 2026
Approval ID: 55889588-c5f1-d9bc-e063-6294a90a5791
Products: 0 registered
Version: 1

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION. DOXORUBICIN HYDROCHLORIDE liposome injection, for intravenous use Initial U.S. Approval: 1995

Quick Stats

Total Products0

Labelers0

Label Sections0

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.